Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2019 Oct 12;8(3):953–964. doi: 10.1016/j.jaip.2019.09.033

Figure 1.

Figure 1.

FEV1, FVC, FEV1/FVC, and FEF25–75 percent predicted values in children (panels A–D, respectively) and adolescents (panels E–H, respectively) at baseline and after 360 mcg, 540 mcg, and 720 mcg of albuterol sulfate. Data are stratified by the dosage of albuterol at which maximal bronchodilation was obtained (red = 360 mcg, blue = 540 mcg, orange = 720 mcg). *p < 0.05